Patrick Morris
6Patents
1h-index
11Co-inventors
48Inventor score
Filing activity: Mar 30, 2000 → Aug 9, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11613514B2 | Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine | Chemistry; Metallurgy | 1 | Active |
| US11897875B2 | Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type a receptors as fast acting treatment for depression and mood disorders | Chemistry; Metallurgy | 0 | Active |
| US10919842B2 | Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine | Chemistry; Metallurgy | 0 | Active |
| US11459320B2 | Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type A receptors as fast acting treatment for depression and mood disorders | Chemistry; Metallurgy | 0 | Active |
| US11186539B2 | Process for synthesis and purification of (2R,6R)-hydroxynorketamine | Emerging Cross-Sectional Technologies | 0 | Active |
| US6309839A | Screening methods for compounds that inhibit or stimulate helicase enzyme activity | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.